Accès à distance ? S'identifier sur le proxy UCLouvain
Rituximab versus tocilizumab and B-cell status in TNF-alpha inadequate-responder rheumatoid arthritis patients: the R4-RA RCT
Primary tabs
- Open access
- 10.03 M
Document type | Article de périodique (Journal article) |
---|---|
Access type | Accès libre |
Publication date | 2022 |
Language | Anglais |
Journal information | "Efficacy and Mechanism Evaluation" - Vol. 9, no.7, p. 1-58 (2022) |
Peer reviewed | yes |
Publisher | National Institute for Health and Care Research (NIHR) |
issn | 2050-4365 |
e-issn | 2050-4373 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/RUMA - Pôle de Pathologies rhumatismales UCL - (SLuc) Service de rhumatologie |
Links |
Bibliographic reference | Humby, Frances ; Durez, Patrick ; Buch, Maya H ; Lewis, Myles J ; Bombardieri, Michele ; et. al. Rituximab versus tocilizumab and B-cell status in TNF-alpha inadequate-responder rheumatoid arthritis patients: the R4-RA RCT. In: Efficacy and Mechanism Evaluation, Vol. 9, no.7, p. 1-58 (2022) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/269792 |